PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.32%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-14.32%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-67.18%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-67.18%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-175.62%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-200.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-200.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
14.57%
Share count expansion well above LBL.AX's 2.48%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.52%
Diluted share count expanding well above LBL.AX's 2.48%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
135.18%
Positive OCF growth while LBL.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
107.63%
Positive FCF growth while LBL.AX is negative. John Neff would see a strong competitive edge in net cash generation.
-77.23%
Negative 10Y revenue/share CAGR while LBL.AX stands at 228.01%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-9.90%
Negative 5Y CAGR while LBL.AX stands at 46.12%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
36.51%
3Y revenue/share CAGR 1.25-1.5x LBL.AX's 25.81%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-89.51%
Negative 10Y OCF/share CAGR while LBL.AX stands at 45.65%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-58.37%
Negative 5Y OCF/share CAGR while LBL.AX is at 30.04%. Joel Greenblatt would question the firm’s operational model or cost structure.
-87.67%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
49.18%
Below 50% of LBL.AX's 196.67%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-32.00%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1200.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
25549.17%
5Y equity/share CAGR above 1.5x LBL.AX's 188.95%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
265.66%
3Y equity/share CAGR above 1.5x LBL.AX's 29.77%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-77.83%
Firm’s AR is declining while LBL.AX shows 32.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
49.04%
Inventory growth well above LBL.AX's 6.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.45%
Positive asset growth while LBL.AX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-22.22%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.16%
We have some new debt while LBL.AX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
55.65%
We increase R&D while LBL.AX cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
15.36%
SG&A growth well above LBL.AX's 28.87%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.